CDSCO Approval License in India: The Complete 2026 Guide

If you've spent any time on CDSCO's website or the SUGAM portal, you already know the problem — the information is scattered across circulars, gazette notifications, and PDF forms with names like MD-14 and MD-9 that mean nothing until someone explains them. This guide puts it all in one place, in plain language, based on how the process actually plays out for manufacturers and importers in 2026.

A CDSCO approval license is the legal authorisation from India's Central Drugs Standard Control Organisation that lets you manufacture, import, or sell a medical device, IVD, drug, or cosmetic in the Indian market. Almost every device gets sorted into Class A, B, C, or D based on risk, and that class decides which form you file, how much you pay, and how long the review takes — anywhere from about 6 weeks for a low-risk Class A device to 9 months or more for a Class D implant. Everything happens online through the SUGAM portal; there's no walking into a CDSCO office with a file folder anymore.

CDSCO Approval License at a Glance

Factor

What to Expect

Governing law

Medical Devices Rules, 2017 (under the Drugs & Cosmetics Act, 1940)

Regulator

Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare

Filing platform

SUGAM online portal

Risk classes

A (low), B (low-moderate), C (moderate-high), D (high)

Manufacturing forms

MD-3, MD-5, MD-7, MD-9 (as applicable)

Import forms

MD-14 / MD-15

Typical timeline

6 weeks – 9 months, class-dependent

Validity

Perpetual for MD licenses, subject to periodic retention fees

Who can apply

Indian manufacturer, or a foreign manufacturer through an Authorised Indian Agent

What Is CDSCO Medical Device Registration, Really?

Strip away the acronyms and it's straightforward: before any notified medical device, IVD, drug, or cosmetic can legally enter the Indian market, someone has to prove to CDSCO that it's safe, that it does what it claims to do, and that whoever is making or bringing it in can be held accountable if something goes wrong. That proof takes the shape of a license or registration certificate.

Skip this step and you're not just risking a rejected shipment — you're looking at customs holds, product seizure, and penalties under the Drugs and Cosmetics Act. Hospitals, government procurement bodies like CGHS and ESIC, and most large distributors also won't touch a device without a valid CDSCO license on file, so in practice it's become a commercial gatekeeping document as much as a legal one.

Who Needs CDSCO Registration?

You need a CDSCO approval license if you fall into any of these buckets:

• You manufacture a notified medical device or IVD anywhere in India

• You import a notified device, IVD, drug, or cosmetic for sale in India

• You're a foreign manufacturer selling into India through a local distributor or agent

• You want to run clinical investigations or trials on a device in India

• You manufacture or sell scheduled cosmetics that require import registration

The word "notified" matters here  CDSCO regulates devices that appear on its notified list, and that list keeps growing. A product you assumed was unregulated a year ago may be on it now.

Who May Not Need a Full Licence?

Not every product needs the heavyweight process, and this is where a lot of applicants either waste money or, worse, assume they're exempt when they aren't.

• Class A Non-Sterile, Non-Measuring (NSNM) devices — following CDSCO's 2025–2026 update, these move through a lighter self-notification pathway on the Medical Device Online Portal instead of the full MD-5/MD-15 licensing route. You still need a registration number; you just don't need the full inspection-heavy license.

• Non-notified devices — if your product genuinely isn't on CDSCO's notified list, it may not require a license at all, though voluntary registration is available and increasingly expected by buyers.

• Devices used purely for research, not sold commercially — different rules apply, usually under a test license.

The catch: "NSNM" is category-specific, not class-wide. A Class A device that's sterile, or that measures something (a thermometer, for instance), falls straight back into the full licensing requirement. Always check your exact product against CDSCO's current NSNM list before assuming you're exempt.

How to Check Whether Your Product Is a Medical Device

CDSCO defines a medical device broadly — instruments, apparatus, implants, software, reagents, and materials intended for diagnosis, prevention, monitoring, treatment, or alleviation of disease, or for investigating a physiological process. Three practical steps:

1. Search the notified devices list on the CDSCO website — if your product or something functionally similar appears there, it's regulated.

2. Check intended use, not just the product name. A wearable that only counts steps is a lifestyle product; the same wearable marketed to detect arrhythmias is a medical device.

3. Use the pre-filing consultation facility on SUGAM if classification is genuinely unclear — getting a written classification opinion before you file saves months compared to a rejection and resubmission later.

CDSCO Medical Device Classification

Every device gets sorted into one of four risk-based classes under MDR 2017. Classification isn't a formality — it decides your form, your fee, your documentation load, and whether you'll face an inspection.

Class A — Low Risk

Devices with minimal potential for harm: hot water bags, elastic bandages, walking aids, examination gloves, non-invasive instruments. Self-notification is often sufficient unless the device is sterile or has a measuring function.

Class B — Low-Moderate Risk

A much larger category — CDSCO's Class B list runs into the hundreds of devices. Think hypodermic needles, suction equipment, and basic diagnostic tools. A license is required, but the documentation burden is manageable and clinical trial data usually isn't.

Class C — Moderate-High Risk

Devices that are implantable for shorter durations, or that support life functions in a limited way — infusion pumps, certain surgical devices, some diagnostic imaging equipment. Expect closer scrutiny of your Device Master File and, in many cases, a facility audit.

Class D — High Risk

Long-term implants, life-sustaining devices, and anything where failure carries serious consequences — cardiac stents, orthopaedic implants, ventilators. These face the fullest review: complete clinical data, mandatory audits, and the longest timelines.

Manufacturing Licence vs Import Licence

These get confused constantly, so here's the difference in one line: a manufacturing licence covers a device made inside India, while an import licence covers a device made outside India and brought in for sale.

• Manufacturing: filed on Form MD-3 (Class A/B) or MD-7 (Class C/D), issued as MD-5/MD-9. Class A and B manufacturing licences are granted by the State Licensing Authority; Class C and D go through the Central Licensing Authority.

• Import: filed on Form MD-14, issued as MD-15, always through the Central Licensing Authority regardless of class.

• Loan licence (manufacturing at someone else's facility): Form MD-8.

If you're a foreign brand entering India, you're almost always looking at the import licence route unless you set up local manufacturing.

CDSCO Registration Process

Here's how the process actually unfolds, step by step.

1. Device identification — Confirm the product meets the legal definition of a medical device and check whether it's on the notified list.

2. Classification — Match it against CDSCO's Class A–D annexures. Use pre-filing consultation if there's any ambiguity.

3. Documentation — Assemble the Device Master File, Plant Master File, ISO 13485 certificate, Free Sale Certificate, test reports, labelling, and — for foreign manufacturers — the Authorised Indian Agent agreement and Power of Attorney.

4. SUGAM application — Create your account, verify it, select the correct form (MD-3/MD-5/MD-7 for manufacturing, MD-14 for import), and upload the dossier.

5. Fee payment — Pay the government fee through the portal's integrated payment gateway, calculated by class and number of products/sites.

6. Review — CDSCO scrutinises the application for completeness and technical merit. This is where most delays happen, through query cycles.

7. Inspection — Class C and D applications, and some Class B ones, involve a facility audit against ISO 13485 and ISO 14971 risk-management standards.

8. Licence issuance — Once queries are closed and (if applicable) the audit is cleared, CDSCO issues the digital licence through SUGAM.

Documents Required

The exact list shifts slightly by class and application type, but a typical CDSCO approval license dossier includes:

• Device Master File (DMF) — covers 20-odd categories of technical evidence under CDSCO's current checklist

• Plant Master File (PMF)

• ISO 13485 Quality Management System certificate

• Free Sale Certificate from the country of origin (for imports)

• CE certificate or equivalent international approval, where available

• Risk management file aligned to ISO 14971

• Labelling and instructions for use, in the prescribed format

• Test reports from an accredited lab

• Power of Attorney and Authorised Indian Agent agreement (foreign manufacturers)

• Latest inspection or audit report from a competent authority, if you have one, from within the last three years

Incomplete or blurred document uploads are one of the most common — and most avoidable — reasons applications stall before they're even reviewed.

SUGAM Portal Process

SUGAM is CDSCO's single online gateway for drugs, devices, and cosmetics applications — there's no offline alternative for standard filings anymore. In practice:

1. Register your company profile with a Digital Signature Certificate for the authorised signatory.

2. Verify your account via the email link.

3. Select the correct application type and form — filing under the wrong form wastes a non-refundable fee.

4. Upload your dossier and pay the challan fee through the integrated banking gateway.

5. Track status and respond to any CDSCO queries directly inside the portal — email responses aren't officially recorded, so always reply through SUGAM itself.

6. Download your digital licence once it's granted.

A newer addition worth knowing about: SUGAM now supports standalone risk-classification applications for medical devices and IVDs, which is useful if you want CDSCO's formal classification opinion before committing to a full filing.

CDSCO Fees

Fees vary by product type, class, number of devices, and number of manufacturing sites, and government fee schedules do get revised — always confirm the live figure on SUGAM before you pay. As a general guide for 2026:

• Class A/B manufacturing licence: around ₹5,000 per site plus roughly ₹500 per device

• Class C/D manufacturing licence: around ₹50,000 per site plus roughly ₹1,000 per device

• Import licence (Form MD-14): typically charged in USD equivalent — roughly USD 1,000 per site for Class A/B, and USD 3,000–5,000 for Class C/D

• Cosmetic import registration: separate fee schedule under COS forms

On top of the government fee, budget for accredited lab testing, notarization and legalisation of foreign documents, and — if you're not handling filing in-house — regulatory consultant charges.

Read more:- BIS ISI certification in India 

 CDSCO Approval Timeline

Realistic timelines, assuming a clean dossier and no major queries:

• Class A: roughly 6–8 weeks

• Class B: roughly 2–3 months

• Class C: roughly 3–6 months

• Class D: roughly 6–9 months, sometimes longer where clinical data is involved

Filing in the first half of the calendar year tends to move a little faster, simply because submission volumes are lower. The single biggest variable, though, isn't your class; it's how fast and completely you answer CDSCO's queries.

Audit & Inspection

CDSCO has been shifting from paperwork-heavy reviews toward risk-based, on-site audits. Class C and D applications should expect a full facility audit checking ISO 13485 compliance and traceability from design through post-market surveillance. Class A and B may face lighter, sampling-based audits rather than a full site visit. Going in with an audit-readiness checklist — document control, CAPA records, and design history files in order — makes the difference between a one-day visit and a drawn-out one.

Common Application Mistakes

• Misclassifying the device and filing under the wrong risk category

• Uploading scanned documents that are blurred, incomplete, or in the wrong format

• Filing under the wrong form (MD-14 vs MD-5 vs MD-9) — the fee isn't refundable if you get this wrong

• Submitting a Device Master File that's missing required evidence categories

• Weak or missing risk-management documentation under ISO 14971

• Inconsistent product naming between the dossier, labelling, and the SUGAM application itself

• Foreign manufacturers skipping the Authorised Indian Agent requirement entirely

Reasons for Delay

Beyond the mistakes above, delays usually trace back to slow query responses, applications left sitting on SUGAM without action (CDSCO has actively been clearing long-pending, unanswered applications rather than leaving them open indefinitely), incomplete clinical evidence for Class C/D products, and audit findings that need corrective action before the licence can be issued.

Foreign Manufacturer & Authorised Indian Agent

Foreign manufacturers (FMCS) cannot file directly on SUGAM. You need an Authorised Indian Agent (AIR) — an India-based entity that holds a wholesale licence, applies on your behalf, manages CDSCO queries and inspections, and acts as your point of accountability in India. This isn't a formality; CDSCO corresponds with the AIR, not with your head office overseas, so choosing an agent who understands your device category matters as much as the paperwork itself.

IVD Registration

In-vitro diagnostics follow the same four-class structure and the same SUGAM process as other medical devices, but with a few IVD-specific expectations: India-specific clinical evaluation or performance data is generally required for Class B–D IVDs, and international approvals like FDA clearance or a CE mark support the file but don't replace local performance data. CDSCO has also been refining classification lists specifically for IVDs, so check the current annexure rather than assuming your product's global classification carries over directly.

Post-Licence Compliance

Getting the licence isn't the finish line. Ongoing obligations include:

• Maintaining post-market surveillance and adverse event reporting

• Paying licence retention fees on the applicable cycle to keep the perpetual licence active

• Updating CDSCO on any change in manufacturing site, product design, or labelling

• Renewing import licences roughly every three years, starting the renewal process about six months ahead

• Keeping quality system records current for any future audit    

CDSCO Licence vs Drug Licence

These two get mixed up often, especially by first-time applicants. A drug licence covers pharmaceuticals — manufacturing, sale, or import of drugs under the Drugs and Cosmetics Act, issued through State Drug Controllers for most categories. A CDSCO medical device licence covers devices, IVDs, and related products under the separate Medical Devices Rules, 2017 framework, with its own classification system, forms, and (for Class C/D) central rather than state authority. If your product is a drug-device combination product, for instance, it may need evaluation under both frameworks, so it's worth getting a classification opinion early rather than assuming one licence covers you.

Why This Process Rewards Getting Expert Help

None of the individual steps here is impossible to do yourself. What trips people up is the accumulation of small decisions — the right classification, the right form, a dossier that anticipates CDSCO's likely questions — where one wrong call early on adds months later. Regulatory consultants who work with CDSCO applications daily aren't selling magic; they're selling the pattern-recognition that comes from having seen which documentation gaps actually trigger queries.

Conclusion

A CDSCO approval license isn't a single form you fill out; it's a process that starts with getting your device classified correctly and ends with an ongoing compliance relationship with the regulator. The applicants who move through it fastest are the ones who treat classification and documentation as the real work, and SUGAM submission as just the last click. Get those fundamentals right, and even a Class C or D filing becomes predictable rather than stressful.

FAQs

What is a CDSCO approval license? 

It's the legal authorisation from India's Central Drugs Standard Control Organisation required to manufacture, import, or sell a notified medical device, IVD, drug, or cosmetic in India.

How long does a CDSCO approval license take? 

Roughly 6–8 weeks for Class A, 2–3 months for Class B, 3–6 months for Class C, and 6–9 months or more for Class D, depending on how quickly queries are answered.

Do I need a licence for a Class A medical device? 

Only if it's sterile or has a measuring function. Class A Non-Sterile, Non-Measuring devices go through a lighter self-notification pathway instead of a full licence.

Can a foreign company apply directly on SUGAM? 

No. Foreign manufacturers must appoint an Authorised Indian Agent to file and manage the application on their behalf.

Is the CDSCO licence valid forever? 

Medical device manufacturing and import licences are perpetual under MDR 2017, subject to paying licence retention fees on the prescribed cycle. Import licences still need renewal roughly every three years.

What's the difference between a manufacturing licence and an import licence? 

A manufacturing licence covers devices made in India; an import licence (Form MD-14/MD-15) covers devices made abroad and brought in for sale here.

Source:-https://mtctecertification.blogspot.com/2026/08/cdsco-approval-license-in-india_0414663391.html